MAIA Biotechnology has developed THIO, a new platform of telomere-targeting agents that attack cancer tumors in a whole new way.
This breakthrough in advanced 3D printing allows Trio to produce metal micro-surgical components faster, cheaper, and more precisely
Cardiol Therapeutics is focused on the development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases
Lumeda is a clinical-stage medical technology company focused on improving treatment outcomes for patients with late-stage cancers
This new platform technology could soon join GLP-1 drugs like Wegovy and Ozempic in the obesity revolution.
CytoVeris is a MedTech company developing AI-powered imaging technology for real-time tissue visualization
A clinical-stage biotech company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases
bit.bio is a synthetic biology company providing human cells for research, drug discovery, and cell therapy
A HealthTech company that provides doctors, clinics, and health systems the tools and support they need to run all aspects of their business
Join our Fireside chat to learn about a potential breakthrough in the treatment of degenerative disc disease
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office